Corvus Pharmaceuticals (CRVS) Non Operating Income (2025 - 2026)
Corvus Pharmaceuticals (CRVS) recorded quarterly Non Operating Income of $1.2 million in Q1 2026, down 95.28% quarter-over-quarter from $25.1 million in Q1 2025, and down 95.28% on a YoY basis from $25.1 million in Q1 2025.
Corvus Pharmaceuticals (CRVS) Non Operating Income (2025 - 2026) Analysis & Trends
Corvus Pharmaceuticals' Non Operating Income history runs 2 years deep, the most recent figure standing at $1.2 million for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 444,000.00 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 9.35 Mn |
| 10 | Corvus Pharmaceuticals | 1.01 Bn | 771.25 Mn | - | 1.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.19 Mn |
| Mar 31, 2025 | 25.12 Mn |